Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2125]

Tepotinib in second line NSCLC treatment

Dr Antonio Passaro and Prof Raffaele Califano

Tepotinib in second line NSCLC treatment ( Dr Antonio Passaro and Prof Raffaele Califano )

Liquid biopsies as translational tools for advancing cancer immunotherapy in...

Dr Bodour Salhia - University of Southern California, Los Angeles, USA

Liquid biopsies as translational tools for advancing cancer immunotherapy in Africa ( Dr Bodour Salhia - University of Southern California, Los Angeles, USA )

Current state of cancer genomics in Africa

Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia

Current state of cancer genomics in Africa ( Dr Wijden Mahfoudh - Faculty of Medicine of Tunis, Tunis, Tunisia )

Exploring genetic essentiality and drug sensitivity in triple-negative breast...

Dr Ricardo Pinto - i3S, Porto, Portugal

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal

Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )

Integrating oncogenetics testing into African clinics and cancer control...

Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria

Integrating oncogenetics testing into African clinics and cancer control programs ( Prof Prisca Adejumo - University of Ibadan, Ibadan, Nigeria )

African Oncogenetics Network: improving training and infrastructure in low...

Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda

African Oncogenetics Network: improving training and infrastructure in low-resource regions ( Dr Achille Manirakiza - King Faisal Hospital, Kigali, Rwanda )

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )

The aims of the African Oncogenetics Network

Dr Yosr Hamdi - Pasteur Institute of Tunis, Tunis, Tunisia

The aims of the African Oncogenetics Network ( Dr Yosr Hamdi - Pasteur Institute of Tunis, Tunis, Tunisia )

Mismatching of unrelated donors beyond a single HLA-locus does not adversely...

Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation ( Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA )

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer

Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer ( Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia )

SABCS 2025: Latest developments in multigene testing in early breast cancer

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2025: Latest developments in multigene testing in early breast cancer ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

More from ecancer